Ever wondered what psychedelic-assisted psychotherapy actually looks like?
Psychedelic-assisted psychotherapy is a rapidly emerging field that utilizes substances like psilocybin and MDMA to help individuals confront and address mental health conditions. It’s important to understand that psychedelic therapy is vastly different from the recreational use of these substances.
TheraPsil is dedicated to building a trusted ecosystem for psychedelic healthcare professionals. Through our rigorous training programs, trainees learn the skills and techniques needed to provide effective support to patients using a research-based, three-phase approach.
So, what does psychedelic-assisted psychotherapy actually entail?
Let’s dive into the 3 phases ⬇️
Phase 1: Preparation Sessions
Establishing trust, setting intentions, and conducting preparatory psychotherapy helps build a strong foundation. Collaborative goal-setting ensures a meaningful experience, and careful consideration of set and setting optimizes the therapeutic environment for healing and personal growth.
Phase 2: The Medicine Session
Under the guidance of trained practitioners, patients participate in carefully administered psychedelic medicine sessions. This controlled exploration of consciousness offers profound insights and facilitates the release of emotional burdens, leading to potential therapeutic breakthroughs. The set, setting, and interpersonal dynamics are carefully managed to foster trust and psychological safety during the psychedelic state.
Phase 3: Integration Sessions
Translating the therapeutic content of the psychedelic experience into practical and sustainable changes in everyday life is the focus of the integration phase. Through structured integration sessions, therapists help patients apply their newfound wisdom, fostering personal growth and long-term well-being.
Learn more about the 3-phase approach to psychedelic therapy from TheraPsil founder, Bruce Tobin by watching this video.